Navigation Links
Small Changes in Two Genes May Trigger Breast Cancer

Testing for genetic variations might reveal women most at risk, researchers say

THURSDAY, May 13 (HealthDay News) -- Slight changes in the expression of two common genes trigger cellular changes that can lead to breast cancer, a new study finds.

The researchers adjusted the expression of the genes -- estrogen receptor alpha and p53 -- in mice but said the tweaks they made in the rodents likely mimic natural variations of the two genes in women.

"It was believed that both of these genes only act once breast cancer had developed," lead investigator Dr. Priscilla A. Furth, a professor of oncology and medicine at Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, said in a news release. She added that p53 mutations are found in many cancers, including breast cancer, and that a majority of breast cancer patients have over-expression of this common estrogen receptor.

"What wasn't known is that different levels of expression of these genes can help launch the cellular changes that lead to breast cancer. That suggests that testing women for their own variations in these genes might potentially give us a clue as to which women are at higher risk for development of breast cancer," she said.

In this study, Furth and colleagues developed mice that lacked one copy of the p53 gene (mice and humans have two copies of this gene, one from each parent). This gene regulates cell growth and is a powerful tumor suppressor. Changes in p53 are seen in 30 percent to 40 percent of breast cancer cases.

In another group of mice, the researchers boosted expression of estrogen receptor alpha by twofold, a level of increase sometimes seen in women. Nearly 70 percent of breast cancer patients have estrogen receptor-positive breast cancer, they noted.

Both groups of mice showed significant precancerous changes in breast tissue. Those changes were even more evident in mice that had one p53 gene as well as twice as much estrogen receptor expression.

"Normal breast tissue functioning requires a balance of cell growth and cell death, and in this study we found that both deregulated estrogen receptor function and p53 expression independently, and in combination, altering this balance and transforming cells," Furth said.

"These are not the only two molecules that are responsible for breast cancer development, but they are important and they can potentially provide us with an early warning or even with prevention strategies," she added.

The study was published online May 13 in the journal Cancer Research.

More information

The U.S. Centers for Disease Control and Prevention has more about breast cancer.

-- Robert Preidt

SOURCE: Georgetown University Medical Center, news release, May 13, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. IPC The Hospitalist Company, Inc. to Present at Deutsche Bank 2010 Small and Mid Cap Conference
2. Omnetics Nano-to-Flex Connectors Solve Big Problems in Small Spaces
3. Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses
4. Even a Small Dietary Reduction in Salt Could Mean Fewer Heart Attacks, Strokes and Deaths
5. Small Cuts in Salt Intake Spur Big Drops in Heart Trouble
6. NSBA 2009 Year-End Economic Report: Small Businesses Still Struggling
7. NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy
8. Union Tax Deal a Slap in the Face to Small Business
9. Smaller Airports May Endanger Health
10. New Disability Income Insurance Options Provide More Choice for Californias Small Business Owners
11. Pay a Dollar, Dress a Child: Helping Struggling Families with Small Donations
Post Your Comments:
(Date:11/25/2015)... ... 2015 , ... The McHenry County law firm of Botto Gilbert Lancaster, ... Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant ... (2d) 130884WC. , According to court documents, Adcock testified that on May 10, 2010 ...
(Date:11/25/2015)... ... ... SCOTTSDALE, AZ) - Today, Dr. Todd C. Hobgood ... non-surgical treatments, announced the expansion of his private practice capabilities with the grand ... trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves the ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... scholarships for people struggling with eating disorders as a result of the $20,000 ... annual event, held at Fox Run Golf Club in Eureka, will help individuals ...
(Date:11/25/2015)... Davie, Florida (PRWEB) , ... November 25, 2015 ... ... PharmaTech LLC has announced that it has undertaken significant expansion of its current ... Florida. The investment is part of PharmaTech’s strategy to increase its manufacturing capacity ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... BOULDER, Colo. , Nov. 24, 2015 /PRNewswire/ ... announced that its Chief Executive Officer, Ron ... Annual Healthcare Conference in New York.  The public ... a webcast on the Array BioPharma website.Event:Piper Jaffray ... OfficerDate:  , Wednesday, December 2, 2015Time:1:30 p.m. Eastern ...
(Date:11/24/2015)... New York , 24. November 2015 ... des Avery Breathing Pacemaker Systems, ist erfreut, ... als Clinical Consultant bekannt geben zu können. ...   --> Foto ... Stockholm (Schweden). Von 1984-1986 war ...
(Date:11/24/2015)... 24, 2015 Avery Biomedical Devices (ABD), manufacturer ... announce the appointment of Anders Jonzon , MD; ... Dr. Jonzon is a Physiologist ... Hospital, Uppsala University, Uppsala and Children,s Hospital, Karolinska, ... a fellow at the Cardiovascular Institute (UCSF). His research ...
Breaking Medicine Technology: